ArticleCell death & disease2022

Artesunate improves venetoclax plus cytarabine AML cell targeting by regulating the Noxa/Bim/Mcl-1/p-Chk1 axis.

Jingyi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.